AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2017
Jul 28, 2017
32939_dirs_2017-07-28_e809c319-b6f9-43fa-9679-cc577d53377d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-07-25
Reporting Person: GOLD JEFFREY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-25 | Common Stock | M | 14000 | $15.75 | Acquired | 66037 | Direct |
| 2017-07-25 | Common Stock | F | 12879 | $17.12 | Disposed | 53158 | Direct |
| 2017-07-26 | Common Stock | A | 7976 | — | Acquired | 61134 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-25 | Non-Qualified Stock Option (right to buy) | $15.75 | M | 14000 | Disposed | 2017-08-03 | Common Stock (14000) | Direct |
Footnotes
F1: The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018.
F2: Options for 33 1/3% of the total number of shares each became exercisable on 8/3/2011, 8/3/2012 and 8/3/2013.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6